Discussion on hot topics and promotion paths for post-market surveillance and supervise of medical consumables based on non-active medical devices
10.3969/j.issn.1672-8270.2024.02.032
- VernacularTitle:无源医疗器械类医用耗材上市后监测监管研究热点与推进路径探讨
- Author:
Fang DONG
1
;
Jianlong YANG
;
Jiayue LI
;
Peng NING
;
Fangfang CHEN
;
Shengnan SHI
;
Xiaolan QIU
;
Zigui XIE
;
Zeshi CUI
Author Information
1. 国家药品监督管理局药品评价中心 北京 100076
- Keywords:
Post-market surveillance;
Non-active medical device;
Medical consumables;
Risk management;
Active surveillance;
Real world research;
Adverse event
- From:
China Medical Equipment
2024;21(2):166-173
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the research hotspots and effective promotion paths of post market surveillance and supervise of medical consumables with non-active medical devices.Methods:Data mining methods were used to collect related journal literatures and documents from the websites of China regulatory institutions and the China National Knowledge Infrastructure(CNKI),order sub item data of medical device adverse event reports,extract the MeSH element words of literatures and documents,perform bibliometric analysis and visual display.Results:The number of medical devices adverse event reports in China has been increasing year by year,reaching 694 866 in 2022,in the four statistical years from 2019 to 2022,the number of reports on non-active medical devices and IVD reagents also showed a parallel increasing trend,accounting for about 65.00% of the total number of adverse event reports on medical devices in the year.The bibliometric analysis of journal literature shows that research in this field has received varying degrees of participation from regulatory institutions,universities,medical institutions,and enterprises.Regulatory institutions have contributed 46 articles,accounting for 56.79% of the total number of articles,followed by 28 articles from universities.The co-occurrence analysis shows that hot topic is focused in 5 clusters:quality management,risk management,international experiences discussion and adverse event surveillance and re-evaluation and real-world research.China regulatory institutions attach great importance to post market surveillance and supervise,and have issued more than 20 relevant documents since 2006,focusing on specific topics and gradually deepening around safety and effectiveness.Conclusion:The post market surveillance and supervise of medical devices,especially medical consumables based on non-active medical devices,need to be promoted synchronously in three dimensions:regulatory institutions,medical institutions,and enterprises.Universities,research institutes,and industry organizations should work in coordinating to strengthen the collection,identification,and active surveillance of risk signals based on adverse event surveillance,safety evaluation based on risk management,and conducting real-world research,research and develop risk control and corrective and preventive measures.
